• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人胰腺分泌型胰蛋白酶抑制剂的放射免疫测定:正常受试者和胰腺疾病患者血清胰腺分泌型胰蛋白酶抑制剂的测定

Radioimmunoassay for human pancreatic secretory trypsin inhibitor: measurement of serum pancreatic secretory trypsin inhibitor in normal subjects and subjects with pancreatic diseases.

作者信息

Kitahara T, Takatsuka Y, Fujimoto K I, Tanaka S, Ogawa M, Kosaki G

出版信息

Clin Chim Acta. 1980 Apr 25;103(2):135-43. doi: 10.1016/0009-8981(80)90205-3.

DOI:10.1016/0009-8981(80)90205-3
PMID:6154549
Abstract

A reliable radioimmunoassay (RIA) for human pancreatic secretory trypsin inhibitor (PSTI) has been developed. The method is highly sensitive (0.4 ng/ml), reproducible and specific. A good parallel relationship was observed between the standard curve and dilution curves for serum and urine. The PSTI bound to trypsin-alpha 2-macroglobulin complexes was found not to be immunoreactive, whereas a part of the psti-trypsin complex was immuno-reactive. In healthy individuals, serum PSTI level ranged from 5.4 ng/ml to 16.0 ng/ml, the average being 11.3 ng/ml (S.D. +/- 2.7). Elevated values were observed in patients with acute pancreatitis (highest value 3200 ng/ml), and in some patients with chronic relapsing pancreatitis.

摘要

已开发出一种用于检测人胰腺分泌型胰蛋白酶抑制剂(PSTI)的可靠放射免疫分析法(RIA)。该方法高度灵敏(0.4 ng/ml)、可重复且具有特异性。在标准曲线与血清和尿液的稀释曲线之间观察到良好的平行关系。发现与胰蛋白酶-α2-巨球蛋白复合物结合的PSTI无免疫反应性,而部分PSTI-胰蛋白酶复合物具有免疫反应性。在健康个体中,血清PSTI水平范围为5.4 ng/ml至16.0 ng/ml,平均为11.3 ng/ml(标准差±2.7)。在急性胰腺炎患者中观察到值升高(最高值3200 ng/ml),并且在一些慢性复发性胰腺炎患者中也有升高。

相似文献

1
Radioimmunoassay for human pancreatic secretory trypsin inhibitor: measurement of serum pancreatic secretory trypsin inhibitor in normal subjects and subjects with pancreatic diseases.人胰腺分泌型胰蛋白酶抑制剂的放射免疫测定:正常受试者和胰腺疾病患者血清胰腺分泌型胰蛋白酶抑制剂的测定
Clin Chim Acta. 1980 Apr 25;103(2):135-43. doi: 10.1016/0009-8981(80)90205-3.
2
A radioimmunoassay for rat pancreatic secretory trypsin inhibitor.大鼠胰腺分泌型胰蛋白酶抑制剂的放射免疫测定法。
Scand J Gastroenterol. 1983 May;18(3):401-5. doi: 10.3109/00365528309181614.
3
On the role of the pancreatic secretory trypsin inhibitor as an inactivator of trypsin-alpha 2-macroglobulin complexes in acute pancreatitis.胰腺分泌性胰蛋白酶抑制剂在急性胰腺炎中作为胰蛋白酶-α2-巨球蛋白复合物失活剂的作用
Hoppe Seylers Z Physiol Chem. 1984 Jul;365(7):751-6. doi: 10.1515/bchm2.1984.365.2.751.
4
Serum pancreatic secretory trypsin inhibitor in pancreatic disease.胰腺疾病中的血清胰分泌性胰蛋白酶抑制剂
Clin Chim Acta. 1984 Sep 29;142(2):231-40. doi: 10.1016/0009-8981(84)90381-4.
5
Appearance mechanism and molecular heterogeneity of serum pancreatic secretory trypsin inhibitor (PSTI).血清胰分泌性胰蛋白酶抑制剂(PSTI)的出现机制及分子异质性
Gastroenterol Jpn. 1985 Aug;20(4):354-60. doi: 10.1007/BF02774746.
6
The measurement of serum immunoreactive pancreatic secretory trypsin inhibitor in gastrointestinal cancer and pancreatic disease.胃肠道癌和胰腺疾病中血清免疫反应性胰腺分泌性胰蛋白酶抑制剂的测定
Int J Pancreatol. 1988 Jul;3(5):323-31. doi: 10.1007/BF02788466.
7
Serum levels of immunoreactive PSTI in acute abdominal disorders, with special reference to a possible extrapancreatic PSTI production.
Clin Chim Acta. 1986 Nov 30;161(1):37-46. doi: 10.1016/0009-8981(86)90261-5.
8
Elevated levels of serum pancreatic secretory trypsin inhibitor (PSTI) in patients with malabsorption syndrome.吸收不良综合征患者血清胰分泌性胰蛋白酶抑制剂(PSTI)水平升高。
Gastroenterol Jpn. 1986 Dec;21(6):617-22. doi: 10.1007/BF02774490.
9
Pancreatic secretory trypsin inhibitor-like immunoreactivity in pancreatectomized patients.胰腺切除患者的胰腺分泌性胰蛋白酶抑制剂样免疫反应性
Clin Chim Acta. 1985 Dec 31;153(3):209-16. doi: 10.1016/0009-8981(85)90354-7.
10
[Experimental studies on the significance of the measurement of serum pancreatic secretory trypsin inhibitor in acute pancreatitis].[血清胰分泌性胰蛋白酶抑制剂测定在急性胰腺炎中意义的实验研究]
Nihon Shokakibyo Gakkai Zasshi. 1985 Aug;82(8):1914-23.

引用本文的文献

1
Granzyme A activates another way to die. granzyme A 激活了另一种死亡方式。
Immunol Rev. 2010 May;235(1):93-104. doi: 10.1111/j.0105-2896.2010.00902.x.
2
Death by a thousand cuts: granzyme pathways of programmed cell death.千刀万剐式死亡:程序性细胞死亡的颗粒酶途径
Annu Rev Immunol. 2008;26:389-420. doi: 10.1146/annurev.immunol.26.021607.090404.
3
Purification and identification of a binding protein for pancreatic secretory trypsin inhibitor: a novel role of the inhibitor as an anti-granzyme A.胰腺分泌型胰蛋白酶抑制剂结合蛋白的纯化与鉴定:该抑制剂作为抗颗粒酶A的新作用
Biochem J. 2003 May 15;372(Pt 1):227-33. doi: 10.1042/BJ20021891.
4
Production and secretion of pancreatic secretory trypsin inhibitor in normal human small intestine.正常人体小肠中胰腺分泌性胰蛋白酶抑制剂的产生与分泌。
J Gastroenterol. 1997 Oct;32(5):623-7. doi: 10.1007/BF02934111.
5
Pancreatic tissue damage by transcatheter arterial embolization for hepatoma.经导管动脉栓塞治疗肝癌所致的胰腺组织损伤
Dig Dis Sci. 1993 Jan;38(1):65-70. doi: 10.1007/BF01296775.
6
Appearance mechanism and molecular heterogeneity of serum pancreatic secretory trypsin inhibitor (PSTI).血清胰分泌性胰蛋白酶抑制剂(PSTI)的出现机制及分子异质性
Gastroenterol Jpn. 1985 Aug;20(4):354-60. doi: 10.1007/BF02774746.
7
Tumour-associated trypsin inhibitor, TATI, in patients with pancreatic cancer, pancreatitis and benign biliary diseases.肿瘤相关胰蛋白酶抑制剂(TATI)在胰腺癌、胰腺炎及良性胆道疾病患者中的情况
Br J Cancer. 1986 Aug;54(2):297-303. doi: 10.1038/bjc.1986.176.
8
Carboxyl ester lipase in human tissues and in acute pancreatitis.人体组织及急性胰腺炎中的羧基酯脂肪酶
Int J Pancreatol. 1989 Sep;5(2):123-34. doi: 10.1007/BF02924413.
9
Tumor-associated trypsin inhibitor in patients with chronic pancreatic diseases.
Klin Wochenschr. 1989 Oct 17;67(20):1029-32. doi: 10.1007/BF01727004.
10
The measurement of serum immunoreactive pancreatic secretory trypsin inhibitor in gastrointestinal cancer and pancreatic disease.胃肠道癌和胰腺疾病中血清免疫反应性胰腺分泌性胰蛋白酶抑制剂的测定
Int J Pancreatol. 1988 Jul;3(5):323-31. doi: 10.1007/BF02788466.